ArticleAnnals of translational medicine2021

CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma.

Shaojie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.